Don Charron
Analyst · B. Riley Capital. Your line is open
Thank you, Ashley, and welcome everyone to our Fourth Quarter Conference Call. Our earnings release was issued yesterday afternoon on the results of our fourth quarter ended June 30, 2016. We have posted a financial summary presentation to accompany this conference call. The presentation can be found on our Investor Relations website within the Event and Presentations tab, or if you are listening via the webcast you can find it in the downloads tab on the webcast portal. I will begin by making a few remarks on the overall quarter and then I will turn it over to Mike for the financial overview. After that, we will answer any questions that you may have. Our sales in the fourth quarter of fiscal year 2016 improved slightly over the previous quarter and were up sharply when compared to the fourth quarter of last year. Continued strength in the automotive end market vertical, combined with sales from new program launches, helped us set a new quarterly sales record in the fourth quarter and a new annual sales record in fiscal year 2016. Sales in our medical end market vertical were up double-digits when compared to the fourth quarter of last year. However they were relatively flat when compared to the previous quarters. We are encouraged by the back-to-back sequential quarterly increases in our sales in the industrial end market vertical which were up 6% from the quarter, which followed a 7% sequential quarterly increase posted in the third quarter. Industrial end market sales were up 8% when you compare the fourth quarter of fiscal year 2016 to the same period last year. However for the full fiscal year 2016 our industrial end market vertical sales were down a disappointing 7% when compared to fiscal year 2015. Our sales and our public safety end market vertical were relatively flat quarter-over-quarter and year-over-year and remained stable at approximately 7% of our total book of business. We continue to make good progress on the launches of a number of new business awards with both existing and new customers. As expected after several quarters of development we begin to see sales from the ramp-up of some of these programs which contributed to our record breaking fourth quarter sales. Our new program launch activity was approximately twice the normal level in fiscal year 2016, and we expect fiscal year 2017 to be at a similar level. Our new business opportunities pipeline remains healthy and we continue to work diligently to achieve our goal of $1 billion in annual sales by fiscal year 2018. We set this goal two years ago and despite the subsequent currency exchange reset caused by the stronger U.S. dollar in a weakening global economic environment, we believe that the goal is still within our reach. We were pleased to have achieved our goal of a 4% operating income in the fourth quarter of fiscal year 2016. But it is important to know that we continue to experience pressure on our margins. We still have work to do in order to consistently achieve our 4% operating income goal. Margin improvement will continue to be a priority of focus for us going forward as we drive variable cost productivity to our Lean, Six Sigma and global supply chain initiatives, and as we look for enterprise-wide productivity improvements in our office support areas. Fiscal year 2017 will be a pivotal year for us as we work through another year of significant programs launches, the ramp up of our new operation in Romania, and the integration of our recent Medivative and Aircom acquisitions. We continue to make excellent progress in Romania. Production for our first industrial customer continues to ramp as planned and we are working on validation plans for additional industrial customers that we expect will launch and ramp over the next several quarters. However, we did not receive approval to begin production from our first automotive customer. It was determined by our customer that additional validation testing is required causing a three-month to four-month delay to our previous plan started production. We now expect to get customer approval to start production in the October to November timeframe. Getting approval to start automotive production is a very important step and requires for us to be able to build a more predictable path to profitability in Romania. We are excited about the recent Medivative and Aircom acquisitions. Aircom, the former parent of Medivative is a key supplier to Medivative. The combination of the two companies adds capabilities and expertise in mechanical design engineering, metal fabrication, injection molding, combination devices, medical instruments and complex system assembly, all to our package of value. As previously announced Medivative is expected to be neutral to slightly accretive to our fiscal year 2017 results. Aircom is expected to be slightly dilutive to our fiscal year 2017 results. While these acquisitions will add to our near-term margin challenge we believe it is an appropriate value creating risk to take it this time. Our plan to leverage our platform to enable more business opportunities for both Medivative and Aircom have already been kicked off and we were recently two new strategically important programs from two different medical customers that will help us solidify our business plans for these two new additions to our footprint. We are also looking at some [indiscernible] versus buy opportunities to improve the short-term utilization of the Aircom operation. And finally, we continue to take advantage of the flexibility provided by our strong balance sheet making investments that would drive future growth in sales and profits. After investing $37 million in capital expenditures in fiscal year 2015, we invested $35 million in capital expenditures in fiscal year 2016, which was slightly below what we expected as we were able to defer a portion of the expenditure to the first quarter of fiscal year 2017. It is important to remind you that a large portion of these capital expenditures directly support new business awards. We are focused on getting through the launch cycle, ramping up production, and ensuring that these new programs and a newly deployed capital that supports them achieve our expected returns. In addition to the $35 million in capital expenditures in fiscal year 2016 we also invested more than $10 million to complete the Medivative and Aircom acquisitions which has strategically positioned us to open new doors for future growth in sales and profit. During the fourth quarter of Fiscal Year 2016, we also returned $5 million to our share owners by purchasing 400,000 shares of our common stock, which brings our total to $13.2 million and 1.2 million shares purchased under the 22 million shares repurchase program approved by our Board in October, 2015. Now I’ll turn it over to Mike to discuss our fourth quarter results in more detail. We will then open the call to your questions. Mike?